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Abstract
A 66 years old Caucasian woman with
pneumococcal meningitis was treated and
discharged after an uncomplicated course.
Five months later she was readmitted with
fever and right side abdominal pain and
diagnosed with pneumococcal spondy-
lodiscitis. One year later she was treated for
a severe chest X-ray confirmed left lobar
pneumonia. Two years later she was diag-
nosed with a pneumococcal pneumonia in
her left lung with septic shock. An immune
deficiency screen revealed slightly reduced
IgA levels, low IgG2 levels, low IgG3 lev-
els and high IgG1 levels. No other immune
defects were identified. She did not respond
serologically on vaccination with 13-valent
conjugate and 23-valent polysaccharide
pneumococcal vaccines. Further evalua-
tions revealed a positive M-component in
her blood and a bone marrow biopsy diag-
nosed her to have monoclonal gammopathy
of undetermined significance. To protect
her against future life threatening pneumo-
coccal infections she was started on treat-
ment with intravenous immunoglobulin.
The case report illustrates the importance of
thorough evaluation of patients with unusu-
al infectious disease entities or unusual fre-
quency of infections in individual patients.
To optimize prophylactic measures and
active treatment options in the individual
patient, it is important to identify underly-
ing causes of diseases and immune defi-
ciencies that potentially can lead to life
threatening infections. This is illustrated in
our case by an undiagnosed monoclonal
gammopathy of undetermined significance
in an apparently healthy woman with at
least three life threatening documented
pneumococcal infections in a two-year peri-
od and poor pneumococcal vaccine
response.
Introduction
Streptococcus pneumoniae is a common
invasive pathogen with pneumonia, sinuitis,
otitis and meningitis as common foci of
infection. It is a rare etiology of spondy-
lodiscitis and endocarditis. Underlying dis-
eases and immune deficiencies can increase
the risk of developing invasive pneumococ-
cal infections.
Case Report 
Pneumococcal infectious episode 1
A previously healthy 66 years old
Caucasian woman was admitted acutely
with reported fever at home, but afebrile
(36.3 degrees Celcius) at arrival to hospital
and with progressive confusion. Objective
findings showed photophobia, confusion
and terminal neck stiffness. She was circu-
latory stable. Her blood chemistry showed
elevated infection parameters (CRP 197
mg/L and leukocytes 17.2×109/L). A spinal
tap showed turbid cerebrospinal fluid (CSF)
with pleocytosis (348×106/L) and 85%
polynucleated leukocytes in the CSF.
Levels of CSF protein was 3.9 g/L and of
CSF glucose 0.8 mmol/L. The Gram stain
of the CSF was negative. The patient was
started in standard treatment for bacterial
meningitis with intravenous
Dexamethasone (10 mg × 4), intravenous
Benzylpenicillin (1.8 g × 6) and intravenous
Ceftriaxone (4 g × 1) according to Danish
guidelines. The patient had received oral
Phenoxymethylpenicillin from her General
Practitioner before admission, and there
was no bacterial growth in the CSF.
However Streptococcus pneumoniae (Sero-
type 15C) grew in one of four blood culture
bottles sampled at the time of hospital
admission. The isolate was fully succeptible
to Penicillin. A Chest X-ray (CXR) at the
time of admission revealed a small basal
pulmonary infiltration on the left side. The
patient responded very well to 10 days of
high dose intravenous Benzylpenicillin (1.8
g × 6) treatment and was discharged after 10
days. She was followed in the outpatient
clinic for a further two months. After two
months she was in her normal health status
with normal blood chemistry and normal
levels of infection markers. She returned to
her normal work as a nurse. 
Pneumococcal infectious episode 2
Five months later she was admitted
again acutely with reported fever at home
but afebrile (36.9 degrees Celcius) at arrival
to hospital. She now had pain in her right
side of the abdomen stretching to the lum-
bar back. In the emergency room her vital
parameters were stable, the abdomen was
soft with no abdominal guarding and she
had normal bowel sounds. CRP (133 mg/L)
and leukocytes (13.3 × 109/L) were elevated
with neutrocytosis. Liver enzymes and alka-
lic phophatases were normal. She did not
appear septic and was not acutely ill. The
clinical picture was quite uncharacteristic
and this initiated several diagnostic proce-
dures including CXR, CT-thorax and CT-
abdomen with no positive findings. Her
blood cultures were negative and she did
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not get any empirical antibiotic treatment
while she went through diagnostic evalua-
tions and observation admitted at the hospi-
tal. After 3 weeks of examinations and
observation her blood chemistry now
showed a significant elevation of the
Erythrocyte Sedimentation Rate of 99. A
new CXR now showed a new compression
fracture of vertebra TH8 in the spine. An
MRI of the spine now showed contrast
enhancement at the level of TH8 and TH9
(Figure 1). Spondylodiscitis was now sus-
pected. She was still without antibiotic
treatment. A CT guided biopsy of the
involved spinal segment was performed and
the bone biopsy showed growth of
Streptococcus pneumoniae. The isolate was
fully succeptible to Penicillin. The patient
was now started in treatment with intra-
venous Benzylpenicillin (1.2 g × 4). After
four weeks of intravenous treatment she
was switched over to oral
Amoxicillin/Clavulanic Acid (500/125 mg
× 3) for further 6 weeks, reaching a total
duration of antibiotic treatment of 10
weeks. The Streptococcus pneumoniae iso-
late identified in the bone biopsy from the
spondylodiscitis was not kept after diagno-
sis, so it has not been possible to serotype
this isolate and verify if the two isolates
from the meningitis and the spondylodisci-
tis were of the same pneumococcal
serotype. A transthoracic echocardiography
revealed normal heart valves without signs
of endocarditis. No transesophageal
echocardiography was performed. The
treatment was successful and her inflamma-
tory biomarkers returned to normal levels
after finishing her treatment for pneumo-
coccal spondylodiscitis. 
Eight months after the last episode with
pneumococcal spondylodiscitis, the patient
had no symptoms, no back pain and was
again working full time as a nurse. After her
pneumococcal spondylodiscitis she was
vaccinated with two pneumococcal vac-
cines within a period of 11 months (first 13-
valent conjugate pneumococcal vaccine
Prevenar® and then 23-valent polysaccha-
ride pneumococcal vaccine Pneumovax®).
Blood testing for serological vaccine
response showed inadequate vaccine
response to the pneumococcal vaccines
indicating that they did not protect her
against the pneumococcal serotypes includ-
ed in both vaccines (Table 1). Control of
vaccination status was performed at the
Danish National Reference Laboratory for
Clinical Microbiology (Statens Serum
Institute, SSI, Copenhagen, Denmark)
using an in-house Luminex bead-based
assay.1 Antibody measurement of specific
anti-pneumococcal IgG antibodies to
serotypes 1, 3, 4, 5, 6B, 7F, 9V, 14, 18C,
19A, 19F and 23F was performed. From the
geometric mean of the 12 serotype specific
antibodies, the vaccination status of the
patient could be determined. After the sec-
ond episode of invasive pneumococcal
infection, the patient was evaluated for pos-
sible immune defects with measurements of
immunoglobulins, IgG subclasses and flow-
cytometric analyses of her leukocyte sub-
types. Low levels of IgG2, of IgG3 and of
IgA levels were observed (Table 2). Very
high levels of IgG1 was observed (Table 2).
CT-abdomen showed a normal spleen and
no signs of lymphoma. CT-thorax showed
no thymoma and no signs of lymphoma. No
immunological action was taken on these
observed low levels of IgG2, of IgG3 and of
IgA at this time.
Infectious episode 3
One year after her pneumococcal
meningitis she was treated by her General
Practitioner with oral antibiotics for a CXR
verified large pneumonia involving the left
lower lobe. CRP was measured to 125 mg/L
by her General Practitioner. She was treated
with Phenoxymethylpenicillin 1600 mg × 2
for 7 days with good clinical response. No
bacterial etiology was identified, but the
CXR was compatible with a classic lobar
pneumonia that could have been caused by
Streptococcus pneumonia.
Pneumococcal infectious episode 4
Two and a half years after her pneumo-
coccal meningitis she was admitted febrile
(39.2 degrees Celcius) with septic shock
and a CXR verified pneumonia. The CRP
was only 18 mg/L at arrival rising to 147
mg/L on the second day of admission. Her
leukocytes at arrival were 12.4 × 109/L with
neutrocytosis. Streptococcus pneumoniae
Serotype 21 was cultured from the sputum.
The isolate was fully succeptible to
Penicillin. Blood cultures were negative.
She was treated with Benzylpenicillin 1.2 g
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Table 1. Levels of specific anti-pneumococcal IgG antibodies (mg/L).
Pneumococcal serotype         September 2015            November 2015           May 2016
Serotype 1                                                          0.18                                           0.05                                  0.61
Serotype 3                                                          0.10                                           0.04                                  0.22
Serotype 4                                                          0.06                                           0.02                                  0.11
Serotype 5                                                          0.08                                           0.04                                  0.14
Serotype 6B                                                       0.12                                           0.04                                  0.28
Serotype 7F                                                       0.33                                           0.12                                  0.59
Serotype 9V                                                       0.43                                           0.13                                  0.28
Serotype 14                                                        1.02                                           0.45                                  0.84
Serotype 18C                                                     0.11                                           0.11                                  0.11
Serotype 19A                                                     1.00                                           0.11                                  1.71
Serotype 19F                                                     0.60                                           0.07                                  2,21
Serotype 23F                                                     1.50                                           0.09                                  1.10
Figure 1. T1 weighted magnetic resonance imaging of the spine without (A) and with (B)
intravenous contrast, shows contrast enhancement in Th8, Th9 and in the discus between
(with permission from the Department of Radiology, National Hospital Faroe Islands)
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× 4 for 5 days and after that for ten days
more with Phenoxymethylpenicillin 800 mg
× 4. After the last episode with life threaten-
ing septic shock with a pneumococcal pneu-
monia as primary focus, immune deficiency
screening (immunoglobulins, IgG subclass-
es and flowcytometric analyses of leuko-
cyte subtypes) was repeated (Table 2) and
based on observed persistent low levels of
IgA, of IgG2 and of IgG 3, intravenous
immunoglobulin substitution (IVIG) thera-
py was started (Privigen®). She still had
very high IgG1 levels (Table 2). She had a
negative HIV test and normal CD4 counts.
She has not had any serious bacterial inva-
sive infections since starting IVIG.
In October 2016, three and a half years
after her pneumococcal meningitis, a blood
test showed a positive M-component. The
identified M-component was an IgG-kappa
chain. The identified M-component in the
blood led to a bone marrow biopsy per-
formed in December 2016. The bone mar-
row biopsy gave the diagnosis of mono-
clonal gammopathy of undetermined signif-
icance (MGUS) with 5-10% plasma cells in
the bone marrow biopsy. The patient is now
followed in the hematological out-patient
clinic for her MGUS and treated with IVIG
to protect her against invasive infections. 
Discussion and Conclusions
Streptococcus pneumoniae is a common
pathogen, but pneumococcal meningitis fol-
lowed by pneumococcal spondylodiscitis
has been described rarely.2,3 In cases of bac-
teremia with Streptococcus pneumoniae,
involvement of multiple organs should
always be considered, especially in high
risk patients (alcohol overconsumption, dia-
betes mellitus, immunosuppression and
after splenectomi).4
Spondylodiscitis will typically have a
subacute debut. Early symptoms can be
unspecific and initially be back pain and
fever like in our case report.5 Conventional
X-ray examinations of the spine are often
normal in the early phases of spondylodisci-
tis. Bone scintigraphy and MRI are sensi-
tive early in the disease process and will
typically give positive findings already after
few days.5 MRI is still considered as the
golden standard with a high sensitivity and
specificity in diagnosing spondylodiscitis.5
PET-CT is getting an increasing role in the
diagnosis of spondylodiscitis and well suit-
ed for patients with contraindications for
MRI. It is important to make efforts in iden-
tifying the microbiological etiology in the
cases of spondylodiscitis. Positive blood
cultures with a pathogen known to be asso-
ciated to spondylodiscitis, combined with
imaging suggesting spondylodiscitis, is
usually considered as enough to have
proven the etiology of the spondylodiscitis,
and start a relevant antibiotic treatment
strategy based on the bacterial finding. With
negative blood cultures, it is important to
try to perform a diagnostic bone biopsy to
identify the pathogen to plan the correct
antibiotic treatment. Another important rea-
son for the bone biopsy is excluding differ-
ential diagnoses as malignant disease in the
spine or tuberculosis as the cause of the
spondylodiscitis (Pott’s disease).5
The patient described in this case report
suffered from two more severe pneumonias
over the next two years after the episode of
pneumococcal spondylodiscitis. This indi-
cated that an underlying cause for infection
including the possibility of immune defi-
ciencies should be considered. An immune
deficiency screening including measure-
ments of immunoglobulins, IgG subclasses
and flowcytometric analyses of the leuko-
cyte subsets was performed. No leukocyte
anomalies were observed and the CD4
count was normal, negative HIV test, nega-
tive SLE autoantibodies and no signs of
lymphoma. Low IgG2 levels and low IgG3
levels were observed on several occasions,
and slightly decreased IgA levels was also
observed. The most common IgG subclass
deficiency is low levels of IgG2 combined
with low levels of IgA.6 The clinical signif-
icance of low IgG subclass deficiencies is
still questionable.7 It is well known that lev-
els of immunoglobulin and IgG subclasses
can fluctuate significantly during infection.6
To make a definitive conclusion
immunoglobulin levels should be measured
repeatedly including in periods where the
patient has no infection. It has been reported
that patients with myelomatosis and MGUS
have lower antibody levels against several
bacteria including Streptococcus pneumo-
nia.8 Because of the combination of several
severe life threatening pneumococcal infec-
tions, in this previously healthy nurse com-
bined with the observation of low levels of
IgG2, of IgG3 and of IgA over several
years, a decision was made to treat her with
IVIG therapy. The combination of low lev-
els of IgG2, of IgG3 and of IgA, and at the
same time very high IgG1 levels led us to
think about alternative diagnoses like
myelomatosis, lymphoma, HIV and SLE. A
positive M-component in her blood fol-
lowed by a bone marrow biopsy revealed
the presence of hematological disease in the
form of MGUS. She has not suffered any
serious bacterial infections after starting
treatment with IVIG. Despite her age of 69
years she is still working part-time as a
nurse and is healthy in all other aspects and
physical active. This case report emphasis
that clinicians encountering unusual infec-
tious disease entities or unusual frequencies
of infectious diseases in the same patient,
should be alert regarding the possibility of
underlying undiagnosed disease and
immune deficiencies. Patients should be
evaluated thoroughly for these risk factors
regarding potential future life threatening
infections in the individual patient.
Identifying underlying diagnoses and
immune deficiencies gives the possibility
for clinical action both regarding prophy-
lactic measures, treatment of underlying
disease, treatment of underlying immune
deficiencies and early rapid diagnoses of
future severe infections. 
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Table 2. Levels of immunoglobulins and subclasses. 
Immunoglobulin, g/L (reference values)                 April 2014a              September 2014b                 November 2014c                May 2015d
IgG total (6.4-13.5)                                                                                    25.4                                         22.2                                                  <0.1                                         29.1
IgA total (0.7-3.12)                                                                                     0.56                                         0.41                                                 <0.25                                        0.35
IgM total (0.56-3.52)                                                                                  1.46                                         1.28                                                 <0.20                                        1.36
IgG1 (2.8-8)                                                                                                 22.4                                         22.6                                                   23.2                                          23.4
IgG2 (1.2-5.7)                                                                                              0.24                                         0.25                                                   0.21                                          0.15
IgG3 (0.24-1.25)                                                                                        0.150                                       0.127                                                 0.089                                        0.089
IgG4 (0.052-1.25)                                                                                      0.267                                       0.254                                                 0.234                                        0.263
aEight months after pneumococcal spondylodiscitis; b13 months after pneumococcal spondylodiscitis; csampled on the 5th day of admission with pneumococcal pneumonia with septic shock; d7 months after pneumo-
coccal pneumonia with septic shock.
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